Continuing Enhanced National Surveillance for Prion Diseases in the United States
The summary for the Continuing Enhanced National Surveillance for Prion Diseases in the United States grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control NCEZID, which is the U.S. government agency offering this grant.
Continuing Enhanced National Surveillance for Prion Diseases in the United States: The Centers for Disease Control and Prevention (CDC) announces the availability of fiscal year (FY) 2022 funds for a cooperative agreement program to continue enhanced national surveillance for human prion diseases in the United States. The purpose of the funding is to continue an active surveillance program similar to that conducted by the National Prion Disease Pathology Surveillance Center (NPDPSC) since 1997 to monitor the occurrence of potentially emerging human transmissible spongiform encephalopathies (TSEs) in the United States. In 1997, in collaboration with the American Association of Neuropathologists (AANP), the National Prion Disease Pathology Surveillance Center was established to enhance national CJD surveillance and to make possible laboratory investigation of newly emerging prion diseases. This pathology center, currently located at Case Western Reserve University in Cleveland, Ohio, provided the services of a cutting edge prion disease laboratory, filling a critical public health gap for monitoring prion diseases in humans. Brain tissues and clinical laboratory information on clinically suspected and diagnosed cases of human prion disease have been evaluated at the NPDPSC for approximately 20 years to confirm diagnoses and determine the type of prion disease, including whether the patients had variant CJD or some other possible emerging prion disease in the United States.
|Federal Grant Title:||Continuing Enhanced National Surveillance for Prion Diseases in the United States|
|Federal Agency Name:||Centers for Disease Control NCEZID (HHS-CDC-NCEZID)|
|Type of Opportunity:||Discretionary|
|Funding Opportunity Number:||CDC-RFA-CK22-2202|
|Type of Funding:||Cooperative Agreement|
|CFDA Descriptions:||Information not provided|
|Current Application Deadline:||March 29th, 2022|
|Original Application Deadline:||March 29th, 2022|
|Posted Date:||January 28th, 2022|
|Creation Date:||January 28th, 2022|
|Archive Date:||April 28th, 2022|
|Total Program Funding:||$20,000,000|
|Maximum Federal Grant Award:||$0|
|Minimum Federal Grant Award:||$0|
|Expected Number of Awards:||1|
|Cost Sharing or Matching:||No|
|Last Updated:||January 28th, 2022|
- Applicants Eligible for this Grant
- State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.) - Unrestricted (i.e., open to any type of entity below), subject to any clarification in text field entitled "Additional Information on Eligibility"
- Additional Information on Eligibility
- Hospitals, Laboratories and other public and/or private entities may apply.
- Grant Announcement Contact
- Tracey Ponder
- Similar Government Grants
- • Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed)
- • Centers for AIDS Research (P30 Clinical Trial Not Allowed)
- • Clinical and Applied Research Strategies for the Prevention and Control of Fungal Diseases
- • Strengthening Training, Evaluation, and Partnerships in the Prevention and Control of Vect...
- • Enhancing Telehealth Strategies to Support Retention and Adherence to Antiretroviral Thera...
- • Impact of Japanese Encephalitis Vaccination in Cambodia
- • Clinical, Epidemiologic and Ecologic Factors Impacting the Burden and Distribution of Monk...
- • Reduction of Malaria in U.S. Residents Returning from Overseas Travel to Malaria-Endemic C...
- More Grants from the Centers for Disease Control NCEZID
- • Strengthening Global Capacity for Molecular Surveillance and Outbreak Response for Enteric...
- • US Public Health Pathogens Genomics Centers of Excellence
- • Strengthening Healthcare Infection Prevention and Control and Improving Patient Safety in ...
- • Reducing the Tuberculosis Burden in U.S. Bound Populations from the Philippines